HIV Drug-Hormone interaction study in transgender women halted early

NCT ID NCT06005610

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times

Summary

This study looked at whether taking estrogen therapy changes the levels of HIV drugs in the blood of transgender women. About 93 adult transgender women living with HIV who were already on stable HIV treatment took part. The goal was to see if the HIV drugs still work well and if estrogen levels stay steady when both are used together.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV I INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Barranco CRS (11301)

    Lima, 4, Peru

  • Case CRS (2501)

    Cleveland, Ohio, 44106, United States

  • Chapel Hill CRS (3201)

    Chapel Hill, North Carolina, 27599-7215, United States

  • Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS (31784)

    Chiang Mai, 50200, Thailand

  • Greensboro CRS (3203)

    Greensboro, North Carolina, 27401, United States

  • Houston AIDS Research Team CRS (31473)

    Houston, Texas, 77030, United States

  • Johns Hopkins University CRS (201)

    Baltimore, Maryland, 21205, United States

  • New Jersey Medical School Clinical Research Center CRS (31786)

    Newark, New Jersey, 07103, United States

  • Nutrición-Mexico CRS (32078)

    Mexico City, Tlalpan, 14080, Mexico

  • Thai Red Cross AIDS Research Centre (TRC-ARC) CRS (31802)

    Bangkok, Patumwan, 10330, Thailand

  • The Ponce de Leon Center CRS (5802)

    Atlanta, Georgia, 30308, United States

  • UCSD Antiviral Research Center CRS (701)

    San Diego, California, 92103, United States

  • University of California, San Francisco HIV/AIDS CRS (801)

    San Francisco, California, 94110, United States

  • University of Colorado Hospital CRS (6101)

    Aurora, Colorado, 80045, United States

  • Vanderbilt Therapeutics CRS (3652)

    Nashville, Tennessee, 37204, United States

  • Washington University Therapeutics (WT) CRS (2101)

    St Louis, Missouri, 63110-1010, United States

  • Weill Cornell Uptown CRS (site 7803)

    New York, New York, 10065, United States

  • Whitman-Walker Institute, Inc. CRS (31791)

    Washington D.C., District of Columbia, 20005, United States

Conditions

Explore the condition pages connected to this study.